//
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association
Genotype-Guided Strategy for Oral P2Y12 Inhibitors
Cholesterol-Lowering Agents
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial
Management of No-Reflow Phenomenon in the Catheterization Laboratory
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials
Advances in Coronary No-Reflow Phenomenon-a Contemporary Review
Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients